Search

everythinglearnresearchcommunity

for

Search:↓

Skin reactions to antidepressants are common but usually not serious and can be treated.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

PCOS increases sexual pain distress in infertile women.

Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.

A young woman developed a bowel obstruction from eating hair extensions, highlighting the need for cultural awareness and research on these behaviors in the Black community.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Gender identity can be more diverse than just male or female.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

Genetic differences affect COVID-19 severity and treatment effectiveness.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

People with alopecia areata have a higher risk of stroke.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Inositol was not more effective than a placebo in treating trichotillomania.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.